Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 199 Total
DLPN - Dolphin Entertainment Inc. - Stock Price Chart
TickerDLPN [NASD]
CompanyDolphin Entertainment Inc.
CountryUSA
IndustryAdvertising Agencies
Market Cap23.31MEPS (ttm)-1.48
P/E-EPS this Y93.49%
Forward P/E3.00EPS next Y472.73%
PEG-EPS past 5Y-8.20%
P/S0.48EPS next 5Y-
P/B1.13EPS Q/Q92.17%
Dividend-Sales Q/Q54.03%
Insider Own8.09%Inst Own8.60%
Insider Trans1.91%Inst Trans11.40%
Short Float0.01%EarningsMay 14/a
Analyst Recom1.00Target Price6.00
Avg Volume119.11K52W Range0.95 - 2.48
May-16-24 09:00AM Dolphin Entertainment is Proud to Share the New 'Blue Angels' Featurette Ahead of the Documentary's Release in IMAX Theaters Nationwide Beginning Tomorrow, May 17, 2024 (ACCESSWIRE)
May-15-24 08:18AM Dolphin Entertainment, Inc. (NASDAQ:DLPN) Q1 2024 Earnings Call Transcript (Insider Monkey) +10.22%
07:29AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-14-24 04:25PM Dolphin Entertainment Q1 2024 Revenue Increases 54% Year over Year to a Record $15.2 Million, and Reports Positive Adjusted Operating Income of $1.0 Million Compared to an Adjusted Operating Loss of $1.9 Million in Q1 2023 (ACCESSWIRE)
May-09-24 04:15PM Dolphin Entertainment to Host First Quarter 2024 Earnings Call on May 14, 2024 at 4:30 PM ET (ACCESSWIRE)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE) +9.58%
Apr-24-24 04:15PM Dolphin Entertainment to Present at the Planet Microcap Investor Conference on May 1, 2024 at 2:30pm PT (ACCESSWIRE)
Apr-18-24 09:00AM Shore Fire Media Elevates Five Staff to New Leadership Roles Reflecting Growth of Company and Roster (ACCESSWIRE)
Apr-09-24 09:00AM Culinary Icon Rachael Ray and Do Good Spirits Partner With Dolphin Entertainment to Provide Marketing Services to Launch Staple Gin (ACCESSWIRE)
Apr-03-24 09:00AM Dolphin Entertainment to Present at the LD Micro Investor Conference in New York City on April 9, 2024 at 2:00pm ET (ACCESSWIRE) -11.19%
ELDN - Eledon Pharmaceuticals Inc - Stock Price Chart
TickerELDN [NASD]
CompanyEledon Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap73.08MEPS (ttm)-1.49
P/E-EPS this Y31.40%
Forward P/E-EPS next Y44.59%
PEG-EPS past 5Y43.37%
P/S-EPS next 5Y-
P/B1.00EPS Q/Q54.47%
Dividend-Sales Q/Q-
Insider Own5.59%Inst Own36.04%
Insider Trans0.00%Inst Trans-1.35%
Short Float0.15%EarningsMay 09/b
Analyst Recom1.00Target Price14.00
Avg Volume168.52K52W Range1.07 - 2.94
May-14-24 12:00PM Eledon Pharmaceuticals (ELDN) Moves to Buy: Rationale Behind the Upgrade (Zacks) +6.85%
May-09-24 01:54PM ELDN Stock Earnings: Eledon Pharma Beats EPS for Q1 2024 (InvestorPlace)
07:30AM Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results (GlobeNewswire)
07:00AM Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress (GlobeNewswire)
May-07-24 07:05AM Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection (GlobeNewswire) -7.38%
07:00AM Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement (GlobeNewswire)
Mar-28-24 04:01PM Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results (GlobeNewswire)
Mar-25-24 04:56PM Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection (GlobeNewswire)
Mar-21-24 10:31AM Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human (GlobeNewswire) +11.24%
Feb-13-24 07:01PM Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
IFRX - InflaRx N.V. - Stock Price Chart
TickerIFRX [NASD]
CompanyInflaRx N.V.
CountryGermany
IndustryBiotechnology
Market Cap95.97MEPS (ttm)-0.76
P/E-EPS this Y6.06%
Forward P/E-EPS next Y-15.88%
PEG-EPS past 5Y9.74%
P/S872.49EPS next 5Y-
P/B0.94EPS Q/Q32.98%
Dividend-Sales Q/Q-
Insider Own17.08%Inst Own23.54%
Insider Trans0.00%Inst Trans-18.47%
Short Float0.27%EarningsMay 08/b
Analyst Recom1.40Target Price8.09
Avg Volume219.09K52W Range1.14 - 4.92
May-08-24 11:57AM IFRX Stock Earnings: InflaRx Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:30AM InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-30-24 07:30AM InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024 (GlobeNewswire)
Apr-24-24 07:30AM InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event (GlobeNewswire)
Mar-21-24 11:53AM IFRX Stock Earnings: InflaRx Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -8.88%
08:45AM InflaRx N.V. (IFRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:00AM InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans (GlobeNewswire)
Mar-19-24 07:30AM InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024 (GlobeNewswire) +12.67%
Feb-22-24 07:30AM InflaRx Appoints Jan Medina as Head of Investor Relations (GlobeNewswire)
Jan-25-24 07:30AM InflaRx Announces Initiation of its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients (GlobeNewswire) -6.25%
LINK - Interlink Electronics - Stock Price Chart
TickerLINK [NASD]
CompanyInterlink Electronics
CountryUSA
IndustryElectronic Components
Market Cap49.60MEPS (ttm)-0.12
P/E-EPS this Y-556.25%
Forward P/E-EPS next Y17.14%
PEG-EPS past 5Y-
P/S3.60EPS next 5Y-
P/B4.11EPS Q/Q-190.14%
Dividend-Sales Q/Q-4.70%
Insider Own98.48%Inst Own0.68%
Insider Trans0.00%Inst Trans10.76%
Short Float7.31%EarningsMay 09/b
Analyst Recom1.00Target Price7.00
Avg Volume7.77K52W Range4.25 - 11.49
May-09-24 09:00AM Interlink Electronics Reports First Quarter 2024 Results (PR Newswire)
Mar-27-24 09:02AM LINK Stock Earnings: Interlink Electronics Reported Results for Q4 2023 (InvestorPlace)
Mar-21-24 09:43AM Interlink Electronics Posts Loss In Q4 - Quick Facts (RTT News)
09:00AM Interlink Electronics Reports Fourth Quarter and Fiscal Year 2023 Results (PR Newswire)
Mar-03-24 02:00PM Take Your Profits! 3 High-Flying Tech Stocks to Sell While You Can (InvestorPlace)
Mar-01-24 09:00AM Interlink Electronics Announces 50% Common Stock Dividend (PR Newswire) +11.82%
Feb-29-24 09:00AM Interlink Electronics, Inc. Presenting and Exhibiting at LOPEC 2024 - the world's leading exhibition and conference for flexible, organic, and printed electronics (PR Newswire) -6.48%
Nov-09-23 09:00AM Interlink Electronics Reports Third Quarter 2023 Results (PR Newswire) +5.28%
Oct-09-23 02:29PM Interlink Electronics, Inc. to Present at Maxim Group LLC Virtual Tech Conference Series: Exploring All Corners of the Tech Sector (PR Newswire)
09:55AM Maxim Group LLC to Host the Virtual Tech Conference Series: Exploring All Corners of the Tech Sector, on Tuesday, October 10th & Wednesday, October 11th at 8:30 A.M. E.T. (GlobeNewswire)
COMM - CommScope Holding Company Inc - Stock Price Chart
TickerCOMM [NASD, RUT]
CompanyCommScope Holding Company Inc
CountryUSA
IndustryCommunication Equipment
Market Cap280.21MEPS (ttm)-8.85
P/E-EPS this Y-111.83%
Forward P/E2.41EPS next Y822.02%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-
P/B-EPS Q/Q-3055.89%
Dividend-Sales Q/Q-41.62%
Insider Own2.07%Inst Own83.25%
Insider Trans9.01%Inst Trans-0.33%
Short Float5.74%EarningsMay 09/b
Analyst Recom3.33Target Price1.21
Avg Volume3.59M52W Range0.86 - 6.64
May-10-24 03:48PM CommScope Holding Company, Inc. (NASDAQ:COMM) Q1 2024 Earnings Call Transcript (Insider Monkey) -5.41%
03:31PM CommScope Holding Co Inc (COMM) Q1 2024 Earnings: Significant Challenges Amidst Declining Sales (GuruFocus.com)
09:39AM CommScope (COMM) Q1 Loss Narrower Than Expected, Sales Fall (Zacks)
02:03AM Q1 2024 CommScope Holding Company Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 03:57PM CommScope Stockholders Approve Proxy Proposals (Business Wire) +5.71%
10:53AM COMM Stock Earnings: CommScope Hldg Co Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:30AM CommScope (COMM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:32AM CommScope: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM CommScope Reports First Quarter 2024 Results (Business Wire)
May-08-24 09:15AM Gear Up for CommScope (COMM) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks) +6.85%
MOGU - MOGU Inc ADR - Stock Price Chart
TickerMOGU [NYSE]
CompanyMOGU Inc ADR
CountryChina
IndustryInternet Retail
Market Cap14.80MEPS (ttm)-2.48
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.00%
P/S0.52EPS next 5Y-
P/B0.18EPS Q/Q-286.38%
Dividend-Sales Q/Q-26.34%
Insider Own0.90%Inst Own24.67%
Insider Trans0.00%Inst Trans-6.12%
Short Float0.13%Earnings-
Analyst Recom1.00Target Price29.40
Avg Volume4.25K52W Range1.41 - 2.92
May-14-24 09:00AM MOGU Announces US$8 Million Share Repurchase Program (Business Wire) +13.01%
Dec-18-23 05:51AM MOGU Stock Earnings: MOGU Reported Results for H1 2024 (InvestorPlace)
Dec-15-23 11:00AM MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023 (Business Wire)
Oct-17-23 08:00AM Baijiayun Announces Change in Management (PR Newswire)
Aug-25-23 12:08PM MOGU Inc's Rocky Road Ahead: Unraveling the Factors Limiting Growth (GuruFocus.com) +6.21%
Jul-31-23 04:00PM MOGU Files Annual Report on Form 20-F for Fiscal Year 2023 (Business Wire)
Jul-27-23 07:05AM Getting In Cheap On MOGU Inc. (NYSE:MOGU) Is Unlikely (Simply Wall St.)
Jun-12-23 08:09AM Companies Like MOGU (NYSE:MOGU) Are In A Position To Invest In Growth (Simply Wall St.) +7.53%
Jun-02-23 01:00AM MOGU Announces Unaudited Financial Results For the Six Months Ended March 31, 2023 and Fiscal Year 2023 (Business Wire)
Apr-21-23 05:00PM MOGU Announces Resignation and Appointment of Directors (Business Wire)
LTBR - Lightbridge Corp - Stock Price Chart
TickerLTBR [NASD]
CompanyLightbridge Corp
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap38.53MEPS (ttm)-0.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y40.19%
P/S-EPS next 5Y-
P/B1.35EPS Q/Q-20.39%
Dividend-Sales Q/Q-
Insider Own14.09%Inst Own8.99%
Insider Trans0.00%Inst Trans9.81%
Short Float0.82%EarningsMay 09/a
Analyst Recom-Target Price-
Avg Volume71.90K52W Range2.28 - 6.70
May-13-24 03:10AM Lightbridge Corp (LTBR) Q1 2024 Earnings Call Transcript Highlights: Advancing Nuclear Fuel ... (GuruFocus.com)
May-12-24 09:36AM Lightbridge Corporation (NASDAQ:LTBR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-11-24 02:11AM Q1 2024 Lightbridge Corp Earnings Call (Thomson Reuters StreetEvents)
May-09-24 04:05PM Lightbridge Provides Business Update and Announces First Quarter 2024 Financial Results (GlobeNewswire)
May-01-24 08:00AM Lightbridge to Hold Business Update & First Quarter 2024 Earnings Conference Call on Friday, May 10th at 11 a.m. ET (GlobeNewswire) +5.65%
Apr-18-24 08:00AM Ambassador Thomas Graham, Jr. Appointed As Chairman Emeritus of Lightbridge Corporation (GlobeNewswire)
Mar-21-24 08:00AM Lightbridge Senior Executives Assume Key Positions in Prestigious Nuclear Energy Industry Groups (GlobeNewswire)
Mar-18-24 06:00AM Lightbridge Achieves Critical Fabrication Development Milestone by Demonstrating the Extrusion Process for Uranium-Zirconium Samples (GlobeNewswire) +12.68%
Mar-13-24 08:00AM Lightbridge Announces Upcoming Nuclear Events (GlobeNewswire)
Mar-01-24 12:09AM Q4 2023 Lightbridge Corp Earnings Call (Thomson Reuters StreetEvents)
KOD - Kodiak Sciences Inc - Stock Price Chart
TickerKOD [NASD, RUT]
CompanyKodiak Sciences Inc
CountryUSA
IndustryBiotechnology
Market Cap173.35MEPS (ttm)-4.44
P/E-EPS this Y26.57%
Forward P/E-EPS next Y-6.05%
PEG-EPS past 5Y-12.42%
P/S-EPS next 5Y12.40%
P/B0.72EPS Q/Q39.40%
Dividend-Sales Q/Q-
Insider Own7.37%Inst Own81.04%
Insider Trans0.00%Inst Trans2.83%
Short Float5.35%EarningsMay 15/a
Analyst Recom4.00Target Price3.50
Avg Volume729.14K52W Range1.37 - 9.80
May-16-24 12:51PM Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus (Zacks)
May-15-24 10:55PM KOD Stock Earnings: Kodiak Sciences Beats EPS for Q1 2024 (InvestorPlace)
04:01PM Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results (PR Newswire)
May-14-24 07:31AM Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug (Clinical Trials Arena)
May-13-24 07:32PM Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy (PR Newswire) +6.09%
May-02-24 04:30PM Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform (PR Newswire)
Apr-04-24 12:09PM Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks (Zacks)
Apr-01-24 05:04PM Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript (Insider Monkey) -15.40%
12:00PM Kodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus (Zacks)
Mar-29-24 10:36AM Q4 2023 Kodiak Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
BYSI - BeyondSpring Inc - Stock Price Chart
TickerBYSI [NASD]
CompanyBeyondSpring Inc
CountryUSA
IndustryBiotechnology
Market Cap104.38MEPS (ttm)-0.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y25.94%
P/S59.64EPS next 5Y-
P/B-EPS Q/Q52.99%
Dividend-Sales Q/Q87.78%
Insider Own39.17%Inst Own2.38%
Insider Trans0.00%Inst Trans-20.45%
Short Float10.00%Earnings-
Analyst Recom2.00Target Price1.25
Avg Volume214.99K52W Range0.65 - 4.00
May-16-24 08:00AM BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics (GlobeNewswire)
May-03-24 07:00AM BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics (GlobeNewswire)
Apr-29-24 05:30PM BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results (GlobeNewswire)
05:30PM BeyondSpring Files 2023 Annual Report on Form 20-F (GlobeNewswire)
Mar-25-24 07:00AM BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer (GlobeNewswire) +11.22%
Feb-26-24 08:00AM BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements (GlobeNewswire) +9.17%
Jan-10-24 03:00PM BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K (GlobeNewswire)
Dec-18-23 04:30PM BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements (GlobeNewswire)
Nov-07-23 07:00AM BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors (GlobeNewswire)
Oct-31-23 08:00AM BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin's Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models (GlobeNewswire)
NRIX - Nurix Therapeutics Inc - Stock Price Chart
TickerNRIX [NASD, RUT]
CompanyNurix Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap984.12MEPS (ttm)-2.65
P/E-EPS this Y-9.70%
Forward P/E-EPS next Y-8.58%
PEG-EPS past 5Y-59.00%
P/S12.17EPS next 5Y-
P/B4.83EPS Q/Q-0.31%
Dividend-Sales Q/Q30.74%
Insider Own6.52%Inst Own80.64%
Insider Trans-0.91%Inst Trans-4.59%
Short Float12.45%EarningsApr 10/b
Analyst Recom1.33Target Price24.67
Avg Volume1.08M52W Range4.22 - 18.12
May-14-24 10:00AM Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024) (GlobeNewswire) +7.25%
07:39AM Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target (MT Newswires)
May-07-24 07:00AM Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference (GlobeNewswire) +7.11%
Apr-16-24 06:21PM Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -5.24%
Apr-11-24 11:38PM Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering (GlobeNewswire) +9.69%
04:00PM Nurix Therapeutics Announces Proposed Public Offering (GlobeNewswire)
Apr-10-24 11:53AM NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) -10.24%
09:29AM Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study (Zacks)
08:31AM Nurix Therapeutics Inc (NRIX) Misses Earnings Predictions But Shows Revenue Growth in Q1 Fiscal 2024 (GuruFocus.com)
08:10AM Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
1⋯7891011121314151617⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.